RNF111

Across TCGA pan-cancer cohorts, RNF111 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated RNF111 data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNF111 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNF111 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

KIRP, HNSC, and LIHC are the cancer types where RNF111 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.244	0.888	<.001	21	view →
HNSC	OS	Median	III,IV	0.087	0.746	<.001	18	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	9	view →
UCEC	DFS	Median	All	0.942	0.826	.023	6	view →
STAD	OS	Median	All	0.123	0.540	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNF111–KIRP (OS)

Open the KIRP breakdown →